Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Final week of September 2023 sees flurry of IPOs from SMEs

EditorMalvika Gurung
Published 09/25/2023, 06:23 AM
Updated 09/25/2023, 06:23 AM
© Reuters.

The final week of September, starting Monday, is set to witness a surge in Initial Public Offerings (IPOs) from several Main and Small Medium-Sized Enterprises (SME) companies on the stock market. This follows last week's listings of three mainboard IPOs: Jupiter Life Line Hospitals, EMS Limited, and RR Kabel.

SW Infrastructure, primarily engaged in construction sector services in the Mumbai and Bandra Suburban regions, opened its IPO on Monday at the National Stock Exchange (NSE). The company aims to raise Rs 2,800 crore ($37.6 million) from this initial issue, with the price band fixed at Rs 113 to Rs 119 per equity share. The investment window will remain open until Wednesday, September 27.

Monday also saw the opening of the IPO for Chennai-based integrated facilities management company Updater Services. The size of this IPO is Rs 640 crore ($8.6 million), with a price range set between Rs 280-300 per share. The offering will also close on Wednesday, September 27.

Visual effects service provider Digicore Studios and Sakshi Medtech and Panels, another SME, launched their IPOs on Monday as well. Digicore aims to raise Rs 30.48 crore ($4.1 million) through its IPO that will continue till Wednesday, while Sakshi Medtech has issued Rs 46.56 lakh ($62,500) of shares this time around.

TV content company Inspire Films also joined the fray on Monday with an IPO issue of Rs 21.23 crore ($2.85 million). The company has produced popular shows such as Sadda Haq, Kuch Rang Pyaar Ke Aise Bhi and Ek Veer Ki Ardaas…Veera and has issued Rs 35.98 lakh shares in the market. The investment opportunity will be available until Wednesday.

Tool manufacturer Sunita Tools is set to launch its IPO on Tuesday, September 26, with a fixed price issue of Rs 22.04 crore ($2.96 million). The issue is a combination of 13.2 lakh shares and includes an offer for the sale of 2 lakh shares. The IPO will be open for investments until Friday, September 29.

Later in the week, on Wednesday, September 27, Paracetamol manufacturing company Valiant Laboratories will launch its IPO. The price band for the company has been set at Rs 133 to Rs 140 per equity share, with the offering closing on October 3.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.